AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, V閞onique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
AbCellera Biologics股票代碼ABCL，員工數量386人，成立日期：12/11/2020。
评论0